Cryoport provides logistics solution and services for Kite Pharma's lead clinical program in cancer immunotherapy

Cryoport, Inc. ("Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, announced that the Company's best-in-class logistics solution is supporting Kite Pharma's ("Kite") clinical program for their lead product candidate, KTE-C19, a CAR-T cell therapy for non-Hodgkin's lymphoma ("NHL").

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Cryoport, Inc. ("Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, announced that the Company's best-in-class logistics solution is supporting Kite Pharma's ("Kite") clinical program for their lead product candidate, KTE-C19, a CAR-T cell therapy for non-Hodgkin's lymphoma ("NHL").

Kite is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT(TM)) designed to restore the immune system's ability to recognize and eradicate tumors.

David Chang, M.D., Ph.D., Kite's Executive Vice President of Research and Development and Chief Medical Officer, commented, "Cryoport has provided valuable cryogenic logistics solutions for our lead clinical program. We are grateful for their professionalism and their support in a role that is contributing greatly to our progress."

Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "We are honored to provide services and solutions to Kite in their efforts to advance a novel immunotherapy treatment that addresses the significant, unmet needs of patients with NHL. We are delighted that Cryoport's validated cryogenic logistics solutions will support Kite in moving closer to eradicating this deadly disease."

>> For more information, click here

 

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences